CERENOME, INC.

CNSY ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item Jun 2024 Mar 2024 Mar 2019 Dec 2018 Sep 2018 Jun 2018 Mar 2018 Dec 2017
Revenue $1.3M $1.7M $703.0K $1.4M $858.0K $660.0K $731.0K $662.0K
Cost of Revenue
Gross Profit $230.0K $30.0K $152.0K $29.0K
Gross Margin 26.8% 4.5% 20.8% 4.4%
Operating Expenses
Research & Development $2.8M $2.8M $1.4M $531.0K $1.2M $1.3M $2.5M $2.4M
SG&A Expense $2.2M $2.2M $1.4M $705.0K $1.3M $1.3M $2.2M $1.6M
Operating Income $-3.7M $-3.3M $-2.2M $-337.0K $-2.2M $-1.8M $-4.4M $-3.6M
Operating Margin -289.1% -196.7% -308.1% -23.7% -259.6% -279.7% -595.3% -548.3%
Interest Expense $27.0K $34.0K $515.0K $542.0K $513.0K $444.0K $423.0K $446.0K
Pretax Income
Income Tax Expense
Net Income $-2.9M $-3.3M $-3.2M $-2.2M $-2.3M $-3.7M $-4.4M $-4.3M
Net Margin -229.9% -194.5% -448.1% -157.2% -271.6% -554.4% -603.1% -647.4%
EPS (Basic) $-0.02 $-0.04 $-0.45 $-1.45 $-1.38 $-1.48 $-0.04 $-0.01
EPS (Diluted) $-0.04 $-0.04 $-0.45 $-1.45 $-1.38 $-1.48 $-0.04 $-0.01
Shares Outstanding (Basic) 130.0M 86.4M 296.6M 5.9M 233.8M 123.5M 1.23B 115.7M
Shares Outstanding (Diluted) 214.9M 86.4M 296.6M 5.9M 233.8M 123.5M 1.23B 115.7M
Dividends Per Share
← Newer Page 2 of 6 Older →